27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
X4 Pharmaceuticals (NASDAQ:XFOR) reported its Q2 earnings results on Thursday, August 4, 2022.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Here's what investors need to know about the announcement.
Earnings
X4 Pharmaceuticals beat estimated earnings by 6.25%, reporting an EPS of $-0.6 versus an estimate of $-0.64.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.11 which was followed by a 15.38% increase in the share price the next day.
To track all earnings releases for X4 Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.